Unmet needs in the management of adult patients with lupus nephritis doi.org/10.1093/ndt/gfag220

Starting the @ERAkidney education meeting in Kaunas with the great support of the Baltic Nephrology Societies. An incredible opportunity to learn and network.

📍 On September 14–15, the Immunonephrology Working Group (IWG) came together at the ERA Headquarters in Parma for its annual face-to-face meeting, a valuable opportunity to review ongoing projects, discuss priorities for the year ahead, and explore new research opportunities. 📸 Here’s a snapshot from the meeting!

A “monstrous” conflict of interest: Kim Fox, ivabradine, and European Society of Cardiology clinical practice guidelines bmj.com/content/394/bmj-2026…

🔔 Don’t miss the Immunonephrology Working Group CME Course: “Current Options and Future Opportunities in Glomerular Diseases” 🗓️ October 16–17, 2026 📍 Łódź, Poland Discover the Scientific Programme and register now 👉 bit.ly/45rz7fL

Ten tips for the diagnosis and management of nephrotic syndrome doi.org/10.1093/ckj/sfag268

The @ERAkidney 10 tips paper for the diagnosis and management of nephrotic syndrome is out! We formulated 5 "positive" and "negative" statements, each incorporating recent developments 5 in the field. academic.oup.com/ckj/advance…

📢NEW publication by the @ERAkidney Immunonephrology Working Group: Management of Recurrent C3 Glomerulopathy After Kidney Transplantation 🔓doi.org/10.1093/ndt/gfag183

🟢Register now for the Immunonephrology Working Group CME Course “Current Options and Future Opportunities in Glomerular Diseases” 🗓️October 16–17, 2026 📍Łódź, Poland Discover more and explore the programme 👉 bit.ly/45rz7fL

⏰⏰⏰One week left to apply for Young Nephrologists Travel Support for ERA IWG CME course in Łódź, Poland in October! Please visit 👉🏻 nephrology-conference.fumed.… and apply! @YNPtweets @ERAkidney @AKronbichler @smirioglu @AnnetteBruchfe1 @IzabelaZakrocka @KateIsabelle24 @nefromn

Looking forward!

Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm dlvr.it/TTgPqQ

Our #IWG @ERAkidney work on disease modification in lupus nephritis has just been published in #NRN nature.com/articles/s41581-0… @IoannisParodis @Lupusreference @smirioglu @LuvacsL @AnnetteBruchfe1 @StefanieSteige6 @sarah_m_moran @OhioStateNeph @KateIsabelle24 et al.

Longitudinal monitoring of proteinuria and eGFR may serve as valuable surrogate endpoints in future clinical trials, helping identify high-risk patients sooner and evaluate treatment effectiveness more efficiently, according to #ASNCJASN study. kidney.pub/CJASN1117?utm_sou… @castro_med @smirioglu

Now open access in @NDTsocial Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties 🧐The challenge is not whether C inhibition is effective but how best to maximize durable benefit, minimize risk, and ensure access ▶️academic.oup.com/ndt/article…

🎥Watch Dr Ozge Hurdogan present the CKJ publication: Clinicopathologic features and outcomes of patients with DNAJB9 positive fibrillary glomerulonephritis oup.cloud.panopto.eu/Panopto…

Infection risk mitigation with #complement inhibitors in #kidney disease ✅ Final version available in @NDTsocial, the official journal of @ERAkidney ➡️ academic.oup.com/ndt/advance…… 🙏 Grateful to all co-authors, incl. @smirioglu @AKronbichler #TMA #aHUS #C3G #ICMPGN #IgAN

🥳THANK YOU to the top CKJ Reviewers of 2025🥳 Nuri Baris Hasbal Wisit Cheungpasitporn Şafak Mirioğlu Marios Papasotiriou 😍Those present at the ERA Congress in Glasgow received a certificate from the Editor-in-Chief and a free Congress registration😍